311 related articles for article (PubMed ID: 26785048)
1. Prognostic Factors and Skeletal-Related Events in Patients with Small Cell Lung Cancer with Bone Metastases at the Time of Diagnosis.
Kang EJ; Lee SY; Kim HJ; Min KH; Hur GY; Shim JJ; Kang KH; Oh SC; Seo JH; Lee SY; Kim JS
Oncology; 2016; 90(2):103-11. PubMed ID: 26785048
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases.
Ulas A; Bilici A; Durnali A; Tokluoglu S; Akinci S; Silay K; Oksuzoglu B; Alkis N
Tumour Biol; 2016 Jan; 37(1):1131-40. PubMed ID: 26276360
[TBL] [Abstract][Full Text] [Related]
3. Spine-specific skeletal related events and mortality in non-small cell lung cancer patients: a single-institution analysis.
Adogwa O; Rubio DR; Buchowski JM; D'Souza A; Shlykov MA; Jennings JW
J Neurosurg Spine; 2022 Jan; 36(1):125-132. PubMed ID: 33254136
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for skeletal-related events in patients with non-small cell lung cancer treated by chemotherapy.
Sekine I; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
Lung Cancer; 2009 Aug; 65(2):219-22. PubMed ID: 19081161
[TBL] [Abstract][Full Text] [Related]
5. The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer.
Delea T; Langer C; McKiernan J; Liss M; Edelsberg J; Brandman J; Sung J; Raut M; Oster G
Oncology; 2004; 67(5-6):390-6. PubMed ID: 15713995
[TBL] [Abstract][Full Text] [Related]
6. Prospective study on the incidence of bone metastasis (BM) and skeletal-related events (SREs) in patients (pts) with stage IIIB and IV lung cancer-CSP-HOR 13.
Katakami N; Kunikane H; Takeda K; Takayama K; Sawa T; Saito H; Harada M; Yokota S; Ando K; Saito Y; Yokota I; Ohashi Y; Eguchi K
J Thorac Oncol; 2014 Feb; 9(2):231-8. PubMed ID: 24419421
[TBL] [Abstract][Full Text] [Related]
7. [Clinical features and prognosis in 104 colorectal cancer patients with bone metastases].
Hong RX; Lin QJ; Luo J; Dai Z; Wang WN
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):787-91. PubMed ID: 24378104
[TBL] [Abstract][Full Text] [Related]
8. Surgical results of metastatic spinal cord compression (MSCC) from non-small cell lung cancer (NSCLC): analysis of functional outcome, survival time, and complication.
Park SJ; Lee CS; Chung SS
Spine J; 2016 Mar; 16(3):322-8. PubMed ID: 26586194
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and prognostic factors in patients with bone metastases from non-small cell lung cancer.
Wu XT; Zhou JW; Pan LC; Ge T
J Int Med Res; 2020 May; 48(5):300060520925644. PubMed ID: 32425092
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Outcomes and a Scoring System for Estimating Survival in Patients Treated With Radiotherapy for Metastatic Spinal Cord Compression From Small-Cell Lung Cancer.
Rades D; Motisi L; Veninga T; Conde-Moreno A; Cacicedo J; Schild SE
Clin Lung Cancer; 2019 Jul; 20(4):322-329. PubMed ID: 31155476
[TBL] [Abstract][Full Text] [Related]
11. Prediction of survival prognosis after surgery in patients with symptomatic metastatic spinal cord compression from non-small cell lung cancer.
Lei M; Liu Y; Tang C; Yang S; Liu S; Zhou S
BMC Cancer; 2015 Nov; 15():853. PubMed ID: 26541141
[TBL] [Abstract][Full Text] [Related]
12. Skeletal metastases in non-small cell lung cancer: a retrospective study.
Tsuya A; Kurata T; Tamura K; Fukuoka M
Lung Cancer; 2007 Aug; 57(2):229-32. PubMed ID: 17451841
[TBL] [Abstract][Full Text] [Related]
13. Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small-cell lung cancer patients treated with first-line platinum-containing chemotherapy.
He M; Chi X; Shi X; Sun Y; Yang X; Wang L; Wang B; Li H
Thorac Cancer; 2021 Dec; 12(23):3101-3109. PubMed ID: 34725930
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for patients with spinal metastases from lung cancer.
Ogihara S; Seichi A; Hozumi T; Oka H; Ieki R; Nakamura K; Kondoh T
Spine (Phila Pa 1976); 2006 Jun; 31(14):1585-90. PubMed ID: 16778693
[TBL] [Abstract][Full Text] [Related]
15. A laboratory prognostic index model for patients with advanced non-small cell lung cancer.
Ulas A; Turkoz FP; Silay K; Tokluoglu S; Avci N; Oksuzoglu B; Alkis N
PLoS One; 2014; 9(12):e114471. PubMed ID: 25474743
[TBL] [Abstract][Full Text] [Related]
16. Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.
Reck M; Thatcher N; Smit EF; Lorigan P; Szutowicz-Zielinska E; Liepa AM; Winfree KB; Peterson P; Guba SC; Socinski MA
Lung Cancer; 2012 Dec; 78(3):276-81. PubMed ID: 23043970
[TBL] [Abstract][Full Text] [Related]
17. Metastatic spinal cord compression in non-small cell lung cancer patients. Prognostic factors in a series of 356 patients.
Rades D; Douglas S; Veninga T; Bajrovic A; Stalpers LJ; Hoskin PJ; Rudat V; Schild SE
Strahlenther Onkol; 2012 Jun; 188(6):472-6. PubMed ID: 22361746
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors for Pathological Fracture and Metastatic Epidural Spinal Cord Compression in Patients With Spinal Metastases.
Hibberd CS; Quan GMY
Orthopedics; 2018 Jan; 41(1):e38-e45. PubMed ID: 29136257
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for skeletal-related events in patients with bone metastasis from breast cancer undergoing treatment with zoledronate.
Miyashita H; Cruz C; Malamud S
Breast Cancer Res Treat; 2020 Jul; 182(2):381-388. PubMed ID: 32474744
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of pretreatment laboratory parameters in combined small-cell lung cancer.
Wang X; Jiang R; Li K
Cell Biochem Biophys; 2014 Jul; 69(3):633-40. PubMed ID: 24554485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
